WO1999022659A1 - Ring electrode structure for diagnostic and ablation catheters - Google Patents
Ring electrode structure for diagnostic and ablation catheters Download PDFInfo
- Publication number
- WO1999022659A1 WO1999022659A1 PCT/US1998/023520 US9823520W WO9922659A1 WO 1999022659 A1 WO1999022659 A1 WO 1999022659A1 US 9823520 W US9823520 W US 9823520W WO 9922659 A1 WO9922659 A1 WO 9922659A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- electrode
- catheter
- tissue
- ring
- ring electrode
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/283—Invasive
- A61B5/287—Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
- A61B2090/065—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension for measuring contact or contact pressure
Definitions
- This invention relates to diagnostic and ablation catheters and, more particularly, to a ring electrode structure for diagnostic and ablation catheters.
- Cardiac dysrhythmias are commonly known as irregular heart beats or racing heart. Two such heart rhythm irregularities are the Wolff-Parkinson- White syndrome and A V nodal reentrant tachycardia. These conditions are caused by an extraneous strand of muscle fiber in the heart that provides an abnormal short-circuit pathway for electric impulses normally existing in the heart. For example, in one type of Wolff-Parkinson- White syndrome, the accessory pathway causes the electric impulses that normally travel from the upper to the lower chamber of the heart to be fed back to the upper chamber.
- VT ventricular tachycardia
- This latter type of cardiac dysrhythmia is a life-threatening arrhythmia.
- Atrial fibrillation is the most commonly occurring type of arrhythmia. It is associated with increased morbidity and mortality due to a higher incidence of thromboembolic events and hemodynamic compromise.
- AV atrioventricular
- Pacemakers may be used to prevent recurrence of paroxysmal AF by either preventing the sinus bradycardia that triggers AF or reducing the interatrial conduction delay.
- Non-surgical procedures such as management with drugs are favored in the treatment of cardiac dysrhythmias.
- arrhythmias are not treatable with drugs, for example, disabling drug resistant AF, and have previously required surgery.
- various incisions are made in the heart to block conduction pathways and thus divide the atrial area available for multiple wavelet reentry and abolish the arrhythmia.
- an Automatic Implantable Cardioverter/Defibrillator can be surgically implanted into the patient, as described in U.S. Patent No.4,817.608 to Shapland et al. While these surgical procedures can be curative, they are associated with increased morbidity and mortality rates, and are extremely expensive. Even the use of an AICD requires major surgical intervention.
- Non-surgical, minimally invasive techniques have been developed which are used to locate cardiac regions responsible for tachycardia, and also to disable the short-circuit function of these areas. According to these techniques, electrical energy shocks are applied to the endomyocardium to ablate cardiac tissue in the arrhythmogenic regions and produce scars which interrupt the reentrant conduction pathways.
- the regions to be ablated are usually first determined by endocardiac mapping techniques. Mapping typically involves percutaneously introducing a diagnostic catheter having one or more electrodes into the patient, passing the diagnostic catheter through a blood vessel (e.g.
- a tachycardial focus is located, as indicated in the electrocardiogram recording, it is marked by means of a fluoroscopic image so that cardiac arrhythmias at the located site can be ablated.
- a conventional electrode catheter having electrodes with a greater surface-area than the diagnostic catheter's electrodes, can then provide electrical energy to the tissue adjacent the electrode to create a lesion in the tissue.
- One or more suitably positioned lesions will create a region of necrotic tissue to disable the malfunction caused by the tachycardial focus.
- Conventional catheter ablation techniques have used catheters each having a single electrode fitted at its tip as one electrical pole.
- the other electrical pole is conventionally provided by a backplate in contact with a patient's external body part to form a capacitive coupling of the ablation energy source (DC, laser, RF, etc.).
- ablation catheters are known in which multiple electrodes are provided, such as the catheter disclosed in allowed U.S. Patent Application Serial No. 08/569,771, filed December 8, 1995, of Mackey, the entirety of which is hereby incorporated by reference as if set forth herein.
- ablation catheters having multiple electrodes are known, from, for example, U.S. Patent 5,779,669 to Haissaguerre, et al., the disclosure of which is hereby incorporated by reference as if set forth herein.
- Ablation is effected by applying energy to the catheter electrodes once the electrodes are in contact with the cardiac tissue.
- the energy can be, for example, RF, DC, ultrasound, microwave, or laser radiation.
- RF energy is delivered between the distal tip of a standard electrode catheter and a backplate, there is a localized RF heating effect. This creates a well-defined, discrete lesion slightly larger than the tip electrode, and also causes the temperature of the tissue in contact with the electrode to rise.
- the rising tissue temperature and changes in impedance at the electrode/tissue interface are sometimes monitored, as disclosed in the aforementioned Mackey patent, to better avoid undesirable complications such as tissue desiccation, blood coagulation, charring at the electrode, thrombus formation, or adhesion of the catheter to the tissue.
- tissue desiccation blood coagulation
- charring at the electrode
- thrombus formation or adhesion of the catheter to the tissue.
- saline-perfused catheters have been used to cool the tip electrode/tissue interface, thereby allowing more power to be delivered without the foregoing undesirable complications.
- a ring electrode structure configured to map tachycardial foci and to form deep lesions in tissue without unduly heating the tissue at the electrode/tissue interface.
- a multielectrode catheter having such an electrode structure with the electrodes being axially spaced from one another for enhanced diagnostic and ablation applications, without sacrificing catheter flexibility.
- a ring electrode structure which has a raised radial dimension such that the electrode projects from the outer diameter of the catheter when mounted thereon.
- the outer diameter of the electrode exceeds that of the catheter on which it is mounted.
- the raised or upstanding ring electrode has a tissue contacting surface that generally contacts tissue within a patient before the catheter itself comes into contact with the tissue.
- This arrangement ensures good and uniform tissue contact for each electrode mounted on the distal end of a catheter.
- This arrangement also enables greater pressure to be applied to this tissue with a reduced force as compared to a conventional electrode catheter configuration, due to the reduced contact area presented by the upstanding ring electrode.
- the ring electrode projects from the catheter on which it is mounted by between about 0.25 french and about 2 french.
- the upstanding electrode has smooth, curved edges to prevent tissue damage when the catheter is advanced and withdrawn from a patient.
- Fig. 1 illustrates, in plan view, the ring electrode structure of the present invention supported on an ablation catheter
- Fig. 2 is a cross-sectional view taken along lines 2-2 of Fig. 1 ;
- Fig.3 is a cross sectional view of a modified ring electrode structure according to the present invention.
- Fig. 4 illustrates the results of an in vitro comparative ablation experiment in which ablation energy was applied for 60 seconds and controlled to not exceed 65 °C;
- Fig. 5 illustrates the results of an in vitro comparative ablation experiment in which ablation energy was applied for 90 seconds and controlled to not exceed 65 °C;
- Fig. 6 illustrates the results of an in vitro comparative ablation experiment in which ablation energy was applied for 120 seconds and controlled to not exceed 65 °C.
- a ring electrode structure 10 supported on a combination diagnostic (mapping) and ablation catheter 12, along a distal portion 14 thereof.
- a tip electrode 16 is provided at the catheter distal end, which may be of conventional design.
- a particularly suitable assembly for the distal tip electrode 16 is described in U.S. Patent No. 5,685,878, issued November 11, 1997, which is hereby incorporated by reference as if set forth in its entirety herein.
- the tip electrode 16 is made of platinum and is attached directly to the distal end of the catheter 12.
- a refractive material may be interposed between the tip electrode 16 (or the other electrodes) and the catheter 12 to protect the supporting catheter from heat during and just after ablation energy has been applied to the electrodes 10,16.
- the ring electrode structure 10 preferably has the same inner diameter as a conventional electrode, that is, slightly smaller than the outer diameter of the catheter 12.
- Each ring electrode is mountable on the catheter 12, for example, by threading a conductive wire 18 soldered or welded to the electrode 10 into a lumen 20 of the catheter through an aperture 22, temporarily stretching the distal portion 14 of the catheter to neck down its outer diameter, slipping the ring electrode 10 over the catheter 12, and releasing the tension on the catheter once the ring electrode is positioned over the aperture 22 (see Fig.2).
- each ring electrode 10 preferably has a temperature sensor 23 mounted along its inner diameter which is seated against the catheter 12, preferably within a cavity in the outer wall of the catheter or in register with the aperture 22, when the ring electrode 10 is mounted to the catheter.
- the temperature sensor 23 can be a thermocouple, thermistor, or resistive thermal device ("RTD").
- Each temperature sensor 23 has an associated conductive lead (not shown) which also extends proximally to the connector.
- the ring electrode 10 has a thickness, as measured in the radial direction R (see Fig. 2), sufficient to cause a contact surface 24 thereof to project from the catheter 12.
- the contact surface 24 generally contacts tissue 26 before the catheter 12 comes into contact with the tissue, even at locations where the tissue has an irregular surface.
- a force is applied in a conventional manner from the proximal end 28 of the catheter 12 to press the electrodes 10, 16 against the tissue 26.
- the upstanding electrodes concentrate the points of tissue contact on the surfaces 24 rather than on the insulating portions 30 of the distal portion 14 of the catheter.
- conventional electrode designs are flush with the outer diameter of the catheter and therefore present a significantly greater contact area with the tissue 26.
- the upstanding ring electrodes 10 of the present invention achieve comparable pressure as is achieved in conventional designs with significantly less applied force. This provides benefits for both mapping and ablation procedures.
- a catheter which includes the electrode 10 is less sensitive to less than optimum tissue contact pressure situations because more electrode surface area of the upstanding electrodes is available to contact the tissue, more RF energy is radiated from the electrode 10, particularly at the electrode edges, and there is a greater likelihood that the electrode will affirmatively engage an irregular tissue surface and focus the contact pressure at the electrodes 10 instead spreading a lessened pressure over a greater contact area which includes both electrodes and the insulative regions 30 (as in conventional designs).
- the upstanding ring electrodes 10 enable significantly deeper and wider lesions to be formed (as taken along the z- and y-axes of Fig. 1, respectively) than conventional electrode designs permit for the same degree of surface tissue temperature and ablation time.
- Each of the ring electrodes was of the same length (4 mm. as taken along the x-axis of Fig. 1) and was mounted on a separate catheter (having an outside diameter of 91 mils (7 French)).
- thermocouple was attached to the inside diameter of each ring electrode at the electrode centerline for sensing the surface tissue temperature. Once mounted, the conventional electrode was flush with the catheter, and the upstanding ring electrode 10 projected by approximately fifteen mils (that is, more than one French). Fifteen grams of force was applied to each electrode to hold it in contact with a tissue sample, and using controlled temperature feedback set to 65 °C, energy was delivered to the electrodes for sixty seconds while 1400 ml/min of saline was flowed.
- the in vitro experiment examined lesion results on a tissue specimen comprising a transverse cross-section of bovine striated muscle tissue approximately 1" long, 0.75" wide, and 0.50" deep.
- An immersible fixture was used to position the electrode with its thermocouple-bearing side was in contact with the tissue specimen.
- fifteen grams of weight was applied to the catheter shaft on either side of the electrode to ensure that the electrode was held firmly against the specimen.
- the fixture enables controlled placement and alignment of an additional thermocouple within the specimen directly below the axial and radial center of the electrode.
- the assembly was submerged in a tank of 37 °C saline/DI water mixture balanced to a 100 ⁇ initial impedance and circulated at 1400 ml/min by a peristaltic pump.
- the ablation procedure and data collection commenced after the assembly equilibriated with the saline/DI water mixture.
- Ablation energy was applied to the specimen for a predetermined duration
- D is the cross-sectional depth from the center point of the surface burn to the deepest margin of the lesion
- W is the surface width
- L is the cross-sectional length at the longest margin
- the calculated lesion volume is equal to ( ⁇ /6)(DWL):
- the upstanding electrode according to the invention outperformed me conventional electrode for each parameter that was measured, as shown in Figs. 4-6 which illustrate the results for three different ablation duration cycles (60, 90 and 120 second cycles, respectively), wherein the "thick" electrode is the electrode 10 and the "thin” electrode is the conventional electrode.
- the ring electrode structure 10 allows more power delivery to better promote lesion formation, as compared to conventional electrode constructions, without increasing tissue surface temperature beyond a clinically acceptable level. Further, enhanced power delivery was obtained without increasing the length of the electrode and without compromising catheter flexibility. As a result, the ring electrodes 10 can be provided with a thickness and axial length suitable for high power ablation.
- the ring electrodes 10 have a smaller contact area than conventional, flush electrodes, they are also suitable for mapping tachycardial foci without blurring the situs of the sensed signal.
- the smaller contact surface 24 of the ring electrode 10 enables both fine signal sensing (like a small antenna), and ablation.
- the power to the electrode 10 may be delivered for durations of about 120 seconds or less to reduce the risk of the electrode 10 adhering to the tissue being ablated and to minimize any tendency that the tissue may have to wrap around the tissue, for example, as a result of tissue dessication.
- the ablation time is increased above, for example, sixty seconds, the lesion cross-sections were observed as being progressively more dense and rubbery to the touch, which may be an indication of increased tissue dessication and a concomitant rise in lesion density. This suggests that the final lesion volume which was measured is less than the actual volume of tissue that was affected by the procedure, particularly in the case of the longer ablation energy cycle durations.
- Fig. 3 illustrates a modification of the ring electrode illustrated in Fig. 1.
- the ring electrode 10' lacks any sharp edges that may cause tissue damage when the catheter 12 is moved within a patient.
- the ring electrode 10' has smooth, curved edges.
- a sheath can be used with this embodiment or the embodiment of Fig. 1 to ensure atruamatic delivery and retraction of the catheter 12.
- the catheter 12 may support only one or an arbitrarily large number of ring electrodes 10.
- the ring electrodes 10 are spaced from each other (and the tip electrode 16) by insulative regions 30, and each can be of an arbitrary axial length.
- the electrodes may be spaced, for example, 1 to 3 mm apart, depending on the thickness of the electrode (as measured in the radial direction) and the range of power to be applied.
- the electrode spacing can also be established with regard to diagnostic considerations such that the electrodes are suitably spaced to map electrical signals within the heart.
- the increased lesion volume resulting from the ring electrode structure of the present invention permits an increase in the inter- electrode spacing along the distal end of the catheter shaft and/or a reduction in the electrode's axial length without sacrificing the ability to create a continuous, linear lesion in the regions between the electrodes 10, that is, beneath insulative regions 30.
- the electrode structure of the present invention permits an increase in tip flexibility by exposing more of the insulative regions 30 of the catheter 12.
- the thickness of the ring electrode 10 may be selected to ensure that the ring electrode has approximately the same mass as the tip electrode 16 or some other predetermined mass. As described above, it is generally desirable to have an axially short electrode 10 so that the focus of a tachycardia signal is not blurred across the length of the electrode. However, the electrode 10 cannot be made to project from the catheter too far or else the catheter will not be readily maneuverable into a desired passageway. Accordingly, a designer must strike a balance between the axial length of the ring electrode 10 and its radial thickness to achieve a predetermined mass.
- the mass of the ring electrode is made to generally match that of the tip electrode 16, and more preferably to substantially match the mass of the tip electrode.
- the arrhythmogenic site is determined by positioning the distal portion 14 of the catheter 12 in the heart and sensing the electrical signals using the ring electrodes 10. Once the arrhythmogenic site is located, a power supply (not shown) is configured to energize the electrodes 10, 16 in either a constant voltage, power, or temperature mode as described in detail in the aforementioned Mackey patent. The electrodes can be energized simultaneously, sequentially, or in accordance with some other pattern. Radio- frequency energy in the range typically of about 250 Khz to 500 Khz is delivered to the electrodes 10,16 to ablate tissue.
- a catheter in accordance with the invention can be packaged with a guide sheath which is sized to accommodate the ring electrodes 10.
- the guide sheath can be a conventional 8 Fr guide, or may be a custom guide sheath which is sized larger than 7.5 Fr.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- Otolaryngology (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Vascular Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Surgical Instruments (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000518602A JP2001521774A (en) | 1997-10-31 | 1998-10-30 | Ring-shaped electrode structure for diagnostic and ablation catheters |
CA002308278A CA2308278A1 (en) | 1997-10-31 | 1998-10-30 | Ring electrode structure for diagnostic and ablation catheters |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6382397P | 1997-10-31 | 1997-10-31 | |
US60/063,823 | 1997-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999022659A1 true WO1999022659A1 (en) | 1999-05-14 |
Family
ID=22051747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/023520 WO1999022659A1 (en) | 1997-10-31 | 1998-10-30 | Ring electrode structure for diagnostic and ablation catheters |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2001521774A (en) |
CA (1) | CA2308278A1 (en) |
WO (1) | WO1999022659A1 (en) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1189544A2 (en) * | 1999-06-03 | 2002-03-27 | C.R. Bard, Inc. | Method and apparatus for performing cardiac ablations |
US9724170B2 (en) | 2012-08-09 | 2017-08-08 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region |
US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
US9999465B2 (en) | 2014-10-14 | 2018-06-19 | Iowa Approach, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10322286B2 (en) | 2016-01-05 | 2019-06-18 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10433906B2 (en) | 2014-06-12 | 2019-10-08 | Farapulse, Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
US10507302B2 (en) | 2016-06-16 | 2019-12-17 | Farapulse, Inc. | Systems, apparatuses, and methods for guide wire delivery |
US10512505B2 (en) | 2018-05-07 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10517672B2 (en) | 2014-01-06 | 2019-12-31 | Farapulse, Inc. | Apparatus and methods for renal denervation ablation |
US10531913B2 (en) | 2010-07-30 | 2020-01-14 | Boston Scientific Scimed, Inc. | RF electrodes on multiple flexible wires for renal nerve ablation |
US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US10624693B2 (en) | 2014-06-12 | 2020-04-21 | Farapulse, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10687892B2 (en) | 2018-09-20 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
US10893905B2 (en) | 2017-09-12 | 2021-01-19 | Farapulse, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
US11020180B2 (en) | 2018-05-07 | 2021-06-01 | Farapulse, Inc. | Epicardial ablation catheter |
US11033236B2 (en) | 2018-05-07 | 2021-06-15 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11259869B2 (en) | 2014-05-07 | 2022-03-01 | Farapulse, Inc. | Methods and apparatus for selective tissue ablation |
US11432870B2 (en) | 2016-10-04 | 2022-09-06 | Avent, Inc. | Cooled RF probes |
US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US12042208B2 (en) | 2018-05-03 | 2024-07-23 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for ablation using surgical clamps |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8986300B2 (en) * | 2012-06-25 | 2015-03-24 | Biosense Webster (Israel) Ltd. | Irrigated electrodes with enhanced heat conduction |
JP6059945B2 (en) * | 2012-10-23 | 2017-01-11 | 株式会社カネカ | Tip loop type electrode sweater |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4817608A (en) | 1987-05-29 | 1989-04-04 | Mieczyslaw Mirowski | Cardioverting transvenous catheter/patch electrode system and method for its use |
US5354297A (en) * | 1992-02-14 | 1994-10-11 | Boaz Avitall | Biplanar deflectable catheter for arrhythmogenic tissue ablation |
WO1997017030A1 (en) * | 1995-11-10 | 1997-05-15 | C.R. Bard, Inc. | Snap-fit distal assembly for an ablation catheter |
WO1997020510A1 (en) * | 1995-12-08 | 1997-06-12 | C.R. Bard, Inc. | Radio frequency energy delivery system for multipolar electrode catheters |
US5685978A (en) * | 1994-11-14 | 1997-11-11 | Petrick; Harold W. | Reclaiming the constituent components of separating and uncured concrete |
US5779669A (en) | 1996-10-28 | 1998-07-14 | C. R. Bard, Inc. | Steerable catheter with fixed curve |
-
1998
- 1998-10-30 WO PCT/US1998/023520 patent/WO1999022659A1/en not_active Application Discontinuation
- 1998-10-30 JP JP2000518602A patent/JP2001521774A/en active Pending
- 1998-10-30 CA CA002308278A patent/CA2308278A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4817608A (en) | 1987-05-29 | 1989-04-04 | Mieczyslaw Mirowski | Cardioverting transvenous catheter/patch electrode system and method for its use |
US5354297A (en) * | 1992-02-14 | 1994-10-11 | Boaz Avitall | Biplanar deflectable catheter for arrhythmogenic tissue ablation |
US5685978A (en) * | 1994-11-14 | 1997-11-11 | Petrick; Harold W. | Reclaiming the constituent components of separating and uncured concrete |
WO1997017030A1 (en) * | 1995-11-10 | 1997-05-15 | C.R. Bard, Inc. | Snap-fit distal assembly for an ablation catheter |
US5685878A (en) | 1995-11-13 | 1997-11-11 | C.R. Bard, Inc. | Snap fit distal assembly for an ablation catheter |
WO1997020510A1 (en) * | 1995-12-08 | 1997-06-12 | C.R. Bard, Inc. | Radio frequency energy delivery system for multipolar electrode catheters |
EP0866675A1 (en) | 1995-12-08 | 1998-09-30 | C.R. Bard Inc. | Radio frequency energy delivery system for multipolar electrode catheters |
US5779669A (en) | 1996-10-28 | 1998-07-14 | C. R. Bard, Inc. | Steerable catheter with fixed curve |
Cited By (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1189544A4 (en) * | 1999-06-03 | 2003-02-05 | Bard Inc C R | Method and apparatus for performing cardiac ablations |
US6616655B1 (en) | 1999-06-03 | 2003-09-09 | C. R. Bard, Inc. | Method and apparatus for performing cardiac ablations |
USRE42724E1 (en) | 1999-06-03 | 2011-09-20 | C.R. Bard, Inc. | Method and apparatus for performing cardiac ablations |
EP1189544A2 (en) * | 1999-06-03 | 2002-03-27 | C.R. Bard, Inc. | Method and apparatus for performing cardiac ablations |
US10531913B2 (en) | 2010-07-30 | 2020-01-14 | Boston Scientific Scimed, Inc. | RF electrodes on multiple flexible wires for renal nerve ablation |
US11426573B2 (en) | 2012-08-09 | 2022-08-30 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region |
US9724170B2 (en) | 2012-08-09 | 2017-08-08 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region |
US9861802B2 (en) | 2012-08-09 | 2018-01-09 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure |
US11589919B2 (en) | 2014-01-06 | 2023-02-28 | Boston Scientific Scimed, Inc. | Apparatus and methods for renal denervation ablation |
US10517672B2 (en) | 2014-01-06 | 2019-12-31 | Farapulse, Inc. | Apparatus and methods for renal denervation ablation |
US11259869B2 (en) | 2014-05-07 | 2022-03-01 | Farapulse, Inc. | Methods and apparatus for selective tissue ablation |
US11241282B2 (en) | 2014-06-12 | 2022-02-08 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
US10433906B2 (en) | 2014-06-12 | 2019-10-08 | Farapulse, Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
US10624693B2 (en) | 2014-06-12 | 2020-04-21 | Farapulse, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
US11622803B2 (en) | 2014-06-12 | 2023-04-11 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
US9999465B2 (en) | 2014-10-14 | 2018-06-19 | Iowa Approach, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
US10835314B2 (en) | 2014-10-14 | 2020-11-17 | Farapulse, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
US10322286B2 (en) | 2016-01-05 | 2019-06-18 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10842561B2 (en) | 2016-01-05 | 2020-11-24 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10433908B2 (en) | 2016-01-05 | 2019-10-08 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US11020179B2 (en) | 2016-01-05 | 2021-06-01 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US11589921B2 (en) | 2016-01-05 | 2023-02-28 | Boston Scientific Scimed, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10709891B2 (en) | 2016-01-05 | 2020-07-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10512779B2 (en) | 2016-01-05 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10507302B2 (en) | 2016-06-16 | 2019-12-17 | Farapulse, Inc. | Systems, apparatuses, and methods for guide wire delivery |
US11432870B2 (en) | 2016-10-04 | 2022-09-06 | Avent, Inc. | Cooled RF probes |
US10016232B1 (en) | 2017-04-27 | 2018-07-10 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
US11357978B2 (en) | 2017-04-27 | 2022-06-14 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for signal generation |
US11833350B2 (en) | 2017-04-28 | 2023-12-05 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10617467B2 (en) | 2017-07-06 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10893905B2 (en) | 2017-09-12 | 2021-01-19 | Farapulse, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
US12042208B2 (en) | 2018-05-03 | 2024-07-23 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for ablation using surgical clamps |
US10709502B2 (en) | 2018-05-07 | 2020-07-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US11033236B2 (en) | 2018-05-07 | 2021-06-15 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
US11020180B2 (en) | 2018-05-07 | 2021-06-01 | Farapulse, Inc. | Epicardial ablation catheter |
US10512505B2 (en) | 2018-05-07 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10687892B2 (en) | 2018-09-20 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10688305B1 (en) | 2019-09-17 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US11738200B2 (en) | 2019-09-17 | 2023-08-29 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11684408B2 (en) | 2019-11-20 | 2023-06-27 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11931090B2 (en) | 2019-11-20 | 2024-03-19 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
Also Published As
Publication number | Publication date |
---|---|
CA2308278A1 (en) | 1999-05-14 |
JP2001521774A (en) | 2001-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999022659A1 (en) | Ring electrode structure for diagnostic and ablation catheters | |
US10709501B2 (en) | Catheter and method for improved ablation | |
US5447529A (en) | Method of using endocardial impedance for determining electrode-tissue contact, appropriate sites for arrhythmia ablation and tissue heating during ablation | |
Langberg et al. | Radiofrequency catheter ablation: the effect of electrode size on lesion volume in vivo | |
US6023638A (en) | System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue | |
US6107699A (en) | Power supply for use in electrophysiological apparatus employing high-voltage pulses to render tissue temporarily unresponsive | |
EP2736434B1 (en) | Intracardiac tool for delivery of electroporation therapies | |
EP0866675B1 (en) | Radio frequency energy delivery system for multipolar electrode catheters | |
US4641649A (en) | Method and apparatus for high frequency catheter ablation | |
US20120232551A1 (en) | Ablative treatment of the heart to improve patient outcomes following surgery | |
US20080161799A1 (en) | Position independent catheter | |
WO1999060923A1 (en) | Electrophysiological treatment methods and apparatus employing high voltage pulse to render tissue temporarily unresponsive | |
JP2012517306A (en) | Ablation catheter and method for electrically insulating heart tissue | |
KR20220014803A (en) | Automatically performing irreversible electroporation ablation during heart refractory period | |
JP4087251B2 (en) | Ablation catheter | |
Lavergne et al. | Transcatheter radiofrequency ablation of atrial tissue using a suction catheter | |
Kalbfleisch et al. | Catheter ablation with radiofrequency energy: Biophysical aspects and clinical applications | |
Willems et al. | Temperature-controlled slow pathway ablation for treatment of atrioventricular nodal reentrant tachycardia using a combined anatomical and electrogram guided strategy | |
Rosenbaum et al. | Advanced radiofrequency catheter ablation in canine myocardium | |
US6443950B1 (en) | Ablation lead for atrial flutter | |
MXPA00004221A (en) | Ring electrode structure for diagnostic and ablation catheters | |
Schwartz et al. | Electrogram patterns associated with successful radiofrequency ablation of accessory pathways in children | |
HAINES et al. | New horizons in catheter ablation | |
JP2015211843A (en) | Ablation catheter and method for electrically insulating cardiac tissue | |
IL308363A (en) | Combined electrodes for tissue Penetrative irreversible Electroporation (IRE) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP MX |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2308278 Country of ref document: CA Kind code of ref document: A Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2000 518602 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2000/004221 Country of ref document: MX Ref document number: 1998957588 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998957588 Country of ref document: EP |